The perfect gift for you and your loved ones. Learn more.
Phosphatidylserine or ashwagandha for cortisol: which to choose?
May 31, 2026
Phosphatidylserine or ashwagandha for cortisol: which to choose?
Last review: May 2026
Both have clinical trials. Both reduce cortisol. But they are not the same thing and do not work for the same people. Phosphatidylserine and ashwagandha act on different stress profiles, with different response speeds and non-overlapping mechanisms. Choosing the wrong one is not dangerous, but it is inefficient.
Here we look at what the studies say — including the negative results that are often omitted — and how to understand which of the two makes sense in your situation, or whether it makes sense to combine them.
Chronically high cortisol manifests in two main ways: as an acute response to a specific stressor (intense exercise, a stressful event, a deadline), or as a persistent baseline elevation linked to chronic psychological stress. These are not the same thing — and here lies the practical difference between the two supplements.
Phosphatidylserine is a membrane phospholipid. It acts at the hypothalamic and pituitary level, modulating the sensitivity of glucocorticoid receptors: essentially, it makes the HPA axis more responsive to the negative feedback of cortisol, so that the post-stress peak falls more rapidly. The effect is greatest on acute cortisol from physical and mental stress.
Ashwagandha (Withania somnifera) is an adaptogen. Its withanolides modulate the activity of the HPA axis, reduce the sensitivity of the nervous system to stress stimuli, and lower baseline cortisol levels over time. The effect is slower — it accumulates over weeks — but broader: it also acts on anxiety, mood, and sleep quality.
They are not alternatives operating on the same mechanism. They are complementary tools working on different phases of the stress response.
Phosphatidylserine and cortisol: what the studies say
The most cited study is that of Monteleone et al. (1990, Neuroendocrinology, PMID 2170852): 8 healthy men on a cycle ergometer, intravenous administration of 50 or 75 mg of phosphatidylserine (derived from bovine brain cortex). Result: both doses significantly attenuated the ACTH and cortisol response to physical stress. It was the first study to demonstrate the direct mechanism on the HPA response.
A subsequent study by Benton et al. (2001, Nutritional Neuroscience, PMID 11842886) tested 300 mg/day of soy phosphatidylserine for one month in adults with high neuroticism traits. The result: less perceived stress and better mood when facing a stressful mental arithmetic task. Serum cortisol was not measured, but the subjective effect was present.
What does not work as well? A study by Kingsley et al. (2005, Medicine & Science in Sports and Exercise, PMID 16118575) tested 750 mg/day of soy PS over 10 days in footballers performing a high-intensity intermittent running protocol. Result: no significant attenuation of post-exercise cortisol. The only positive effect was a tendency towards improved endurance.
The difference between the two results? Most likely the source: bovine PS has a different fatty acid composition compared to soy PS, and the oral bioavailability of PS in general is lower than intravenous infusion. This does not mean that oral soy PS does not work — but it explains why studies on intense exercise give less clear-cut results.
Oral PS shows more consistent effects on cortisol from chronic mental stress and stress from moderate-intensity exercise, with doses of 300–400 mg/day and at least 2–4 weeks of intake.
Phosphatidylserine 450 mg + Organic Moringa — RedMoringa's cortisol protocol: non-GMO soy phosphatidylserine at clinical dosage, combined with traceable moringa for anti-inflammatory support.
Ashwagandha and cortisol: the latest clinical evidence
Ashwagandha has a more extensive and more recent portfolio of evidence on cortisol than phosphatidylserine. A 2024 meta-analysis published in Explore (Arumugam et al., PMID 39348746) analysed 9 randomised controlled trials on 558 patients: ashwagandha reduced serum cortisol by −2.58 µg/dL (95% CI: −4.99; −0.16) compared to placebo. The perceived stress scale (PSS) and the Hamilton Anxiety Rating Scale (HAM-A) also improved significantly.
One of the included trials (Lopresti et al. 2019, Medicine, PMID 31517876): 60 adults, 240 mg Shoden (standardised extract) vs. placebo, 60 days. Morning cortisol reduced in a statistically significant way (p<0.001), together with a reduction in anxiety (HAM-A p=0.040).
Even more recent: a 2026 trial (West et al., Journal of Medicine and Life, PMID 41815853) used serum cortisol at 8 weeks as the primary endpoint in 141 healthy adults with moderate stress. The ashwagandha group showed significant cortisol reductions, with improvements on PSS, HAM-A and OHQ scales compared to placebo.
The main mechanism is modulation of the HPA axis through withanolides — in particular by inhibiting cortisol secretion from the adrenal glands and reducing the sensitivity of stressed neurons to adrenergic stimulation. Unlike phosphatidylserine, the effect is not primarily on the acute peak, but on the baseline cortisol levels over the course of weeks.
The right question is not "which is better" but "for which situation". There are three typical scenarios:
Scenario 1 — Acute performance stress. You are an athlete, have competition stress, cortisol spikes after training and does not come down. Or you have intense work periods with high cortisol in response to specific deadlines. In this case phosphatidylserine is the most appropriate tool: it attenuates the peak, improves recovery, reduces post-stress cortisol.
Scenario 2 — Chronic psychological stress. You are always in "alert mode", sleep poorly, have diffuse anxiety, morning baseline cortisol is consistently high. Ashwagandha has more evidence for this profile: it modifies the set point of the HPA axis over weeks, not just managing the peak.
Scenario 3 — Both. You have chronic stress with frequent acute peaks. In this case the two molecules complement each other well because they cover different layers: PS manages the acute peaks, ashwagandha works on the baseline level. They are not overlapping and do not interfere. There are no combination studies in humans, but no known contraindication to co-administration.
A third layer — the role of moringa — is that of downstream inflammation: as discussed in our article on moringa and cortisol, moringa does not lower cortisol directly but reduces the inflammatory damage that chronic cortisol activates. This is why the RedMoringa product combining phosphatidylserine 450 mg with organic moringa covers two of the three layers with a single formula.
Frequently Asked Questions about phosphatidylserine and ashwagandha for cortisol
Phosphatidylserine or ashwagandha: which lowers cortisol more?
Ashwagandha has stronger evidence for reducing serum cortisol: a 2024 meta-analysis of 9 controlled trials (558 patients) showed a mean reduction of −2.58 µg/dL vs. placebo. Phosphatidylserine has older studies and more variable results with the oral soy form, but acts better on acute cortisol from physical or mental stress. If the goal is to lower chronic baseline cortisol, ashwagandha has more support. For acute cortisol from performance or situational stress, phosphatidylserine is more appropriate.
Can you take phosphatidylserine and ashwagandha together?
There are no combination studies, but no known interaction. The two supplements act on different phases of the cortisol response: PS attenuates acute peaks, ashwagandha lowers the long-term baseline level. For someone with chronic stress and frequent acute peaks, the combination is mechanistically rational. Do not exceed the individual recommended doses and consult a doctor if taking other medications.
How long does it take to see results with phosphatidylserine?
Subjective effects (perceived stress, mood, sleep quality) are usually observed after 2–4 weeks of continuous intake at 300–450 mg/day. Effects on post-exercise cortisol may be faster, while the impact on chronic baseline cortisol is less well documented for PS compared to ashwagandha. The response depends a lot on the type of stress and the quality of the extract.
Does ashwagandha really lower serum cortisol?
Yes, with clinical evidence in humans. The meta-analysis by Arumugam et al. (2024) on 9 randomised controlled trials documented a mean cortisol reduction of −2.58 µg/dL vs. placebo (95% CI: −4.99; −0.16). A 2026 trial (West et al.) used serum cortisol at 8 weeks as the primary endpoint, confirming the reduction. The mechanism runs through modulation of the HPA axis by withanolides.
Does phosphatidylserine have contraindications?
Soy phosphatidylserine is generally well tolerated. The main documented interaction concerns anticoagulants (warfarin): PS has a mild anticoagulant activity and may potentiate its effect. Those taking warfarin or other anticoagulants should consult a doctor before taking PS. High doses (above 600 mg/day) may cause gastrointestinal disturbances in sensitive subjects. There are no absolute contraindications at standard doses (300–450 mg/day) for healthy adults.
Is ashwagandha safe for everyone?
Ashwagandha is contraindicated in pregnancy (risk of spontaneous abortion reported in the literature), in the presence of autoimmune disorders (stimulates the immune system), with immunosuppressants, sedatives or thyroid medications. Those with hypothyroidism should be careful: ashwagandha can increase T3 and T4 levels and interfere with pharmacological dosing. In healthy adults, standard doses (240–600 mg/day of standardised extract) are considered safe in studies of up to 8–12 weeks.
The choice is not "which is better" — it is which fits your stress profile. For acute performance stress, phosphatidylserine is the right tool. For chronic stress with high baseline cortisol, ashwagandha has more direct evidence. For those wanting to cover both layers without managing two separate supplements, the phosphatidylserine + organic moringa formula offers the cortisol-specific support of PS with the anti-inflammatory backing of moringa.